Dynamics simulation and in vitro studies of betulinic acid derivative with liver X receptor DOI
Pan Yu, Weiya Cao, Yuan Wang

et al.

Journal of Biomolecular Structure and Dynamics, Journal Year: 2023, Volume and Issue: 42(13), P. 7014 - 7023

Published: July 27, 2023

Molecular dynamics simulation of the dominant conformational conjugate was performed for 40 ns and 100

Language: Английский

Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis DOI Creative Commons
Minghua Yang, Ke Liu, Pan Chen

et al.

Cell Death and Disease, Journal Year: 2022, Volume and Issue: 13(10)

Published: Oct. 29, 2022

Reprogramming lipid metabolism is considered a fundamental step in tumourigenesis that influences ferroptosis. However, molecular mechanisms between and ferroptosis remain largely unknown. Results from the drug screening of 464 inhibitors (for 164 targets) applied to cells indicated 4 targeted bromodomain-containing protein (BRD4) significantly inhibiting erastin-induced Functional studies proved loss BRD4 weakened oxidative catabolism mitochondria, protecting excessive accumulation peroxides. Mechanism research revealed transcriptional levels fatty acid metabolism-related genes (HADH, ACSL1 ACAA2) participating β-oxidation acids (FAO) polyunsaturated (PUFAs) synthesis depended on activity super-enhancers (SEs) formed by HMGB2 their promoter regions. Conclusively, this study demonstrated was indispensable for based its epigenetic regulatory affecting ferroptosis, providing new theoretical reference understanding relationship deeply.

Language: Английский

Citations

21

HDAC2 promotes colorectal tumorigenesis by triggering dysregulation of lipid metabolism through YAP1 DOI
Zhanghan Chen, Weifeng Hong, Bing Li

et al.

Cellular Signalling, Journal Year: 2025, Volume and Issue: unknown, P. 111627 - 111627

Published: Jan. 1, 2025

Language: Английский

Citations

0

Intermittent Fasting DOI
Beatriz Peñalver Bernabé, Manoela Lima Oliveira, Patricia G. Wolf

et al.

Endocrinology and Metabolism Clinics of North America, Journal Year: 2025, Volume and Issue: 54(1), P. 61 - 83

Published: Feb. 5, 2025

Language: Английский

Citations

0

Colorectal Cancer: Pathogenesis and Targeted Therapy DOI Creative Commons
Jingyuan Li,

Jiashu Pan,

Lisheng Wang

et al.

MedComm, Journal Year: 2025, Volume and Issue: 6(3)

Published: March 1, 2025

Colorectal cancer (CRC) ranks among the most prevalent malignant neoplasms globally. A growing body of evidence underscores pivotal roles genetic alterations and dysregulated epigenetic modifications in pathogenesis CRC. In recent years, reprogramming tumor cell metabolism has been increasingly acknowledged as a hallmark cancer. Substantial suggests crosstalk between metabolic modifications, highlighting complex interplay genome that warrants further investigation. Biomarkers associated with characteristics CRC hold significant clinical implications. Nevertheless, elucidating genetic, epigenetic, landscapes continues to pose considerable challenges. Here, we attempt summarize key genes driving onset progression related regulators, clarify gene expression signaling pathways regulation, explore potential events reprogramming, providing comprehensive mechanistic explanation for Finally, by integrating reliable targets from genetics, epigenetics, processes promise translation into practice, aim offer more strategies overcome bottlenecks treatment.

Language: Английский

Citations

0

Selenium nanoparticles inhibit the formation of atherosclerosis in apolipoprotein E deficient mice by alleviating hyperlipidemia and oxidative stress DOI

Shengze Xiao,

Mao Long, Junying Xiao

et al.

European Journal of Pharmacology, Journal Year: 2021, Volume and Issue: 902, P. 174120 - 174120

Published: April 24, 2021

Language: Английский

Citations

27

IGF2BP3/ESM1/KLF10/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming DOI Creative Commons
Anbo Gao, Juan Zou, Tian Zeng

et al.

Cell Death and Disease, Journal Year: 2025, Volume and Issue: 16(1)

Published: April 17, 2025

Abstract Ovarian cancer (OC) is often detected at an advanced stage and has a high recurrence rate after surgery or chemotherapy. Thus, it essential to develop new strategies for OC treatment. This study tended investigate the effects of endothelial cell-specific molecule 1 (ESM1) in OC. The impact ESM1 on lipid metabolism was investigated through regulation expression. Differential genes regulated by were screened mRNA sequencing. role autophagy explored using inhibitor chloroquine (CQ). Co-IP, dual-luciferase reporter assay, actinomycin D treatment others used analyze mechanism metabolism. xenograft mouse model constructed explore development. regulatory patient samples verified microarray analysis Log-rank (Mantel-Cox) test. After silencing, cholesterol synthesis decreased lipolysis increased. sequencing revealed that related Beclin (BECN1). In vitro experiments, inhibited suppressing BECN1-mediated autophagy. BECN1 expression transcription factor Kruppel-like 10 (KLF10). competitive binding between HSPA5 promoted ubiquitination degradation HMGCR, thereby inhibiting production. intervention experiment with exogenous showed positive correlation m6A reader IGF2BP3 content. Mechanistically, stability mRNA. vivo modified methylation lipolysis. High predicted poor prognosis patients. IGF2BP3/ESM1/KLF10/BECN1 feedback, which promising target

Language: Английский

Citations

0

LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases DOI Creative Commons
Shifeng Huang, Xiaofei Peng,

Lianggui Jiang

et al.

Frontiers in Pharmacology, Journal Year: 2021, Volume and Issue: 12

Published: Aug. 4, 2021

Lipid metabolism is an essential biological process involved in nutrient adjustment, hormone regulation, and lipid homeostasis. An irregular lifestyle long-term overload can cause lipid-related diseases, including atherosclerosis, myocardial infarction (MI), obesity, fatty liver diseases. Thus, novel tools for efficient diagnosis treatment of dysfunctional are urgently required. Furthermore, it known that lncRNAs based regulation like sponging microRNAs (miRNAs) or serving as a reservoir play role the progression Accordingly, better understanding regulatory roles diseases would provide basis identifying potential biomarkers therapeutic targets This review highlighted latest advances on summarised current knowledge dysregulated their molecular mechanisms. We have also provided insights into underlying mechanisms which might serve The information presented here may be useful designing future studies advancing investigations diagnosis, prognosis, therapy

Language: Английский

Citations

22

Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer DOI
Yao Shen, Mao Sun, Jun Zhu

et al.

Molecular Omics, Journal Year: 2021, Volume and Issue: 17(3), P. 464 - 471

Published: Jan. 1, 2021

Metabolic reprogramming is a hallmark of cancer, which still far from being fully understood in colorectal cancer. In order to characterize the metabolic changes we performed metabolomics analysis paired colon tissues cancer patients by using liquid chromatography-mass spectrometry (LC-MS)-based method. Bioinformation was used define important metabolites and pathways, as well prognosis significance expression levels key molecules. The results indicated that metabolite phenotype cancerous obviously different their normal counterpart, identified series including decreased trends glucose, citrate, serotonin, 5-hydroxytryptophol 5-hydroxyindoleacetate, increased glutamate, glutathione, creatine, proline, lactate, fructose 1,6-bisphosphate, succinate, tryptophan, kynurenine long chain acyl-carnitines. These are mainly implicated energy metabolism, amino acid glutathione metabolism fatty metabolism. addition, found several molecules these pathways were closely correlated with patients. This study characterizes profile provides more insightful understanding

Language: Английский

Citations

21

METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1 DOI

Dehua Xu,

Shuguang Han, Xiao‐Guang Yue

et al.

Molecular Biotechnology, Journal Year: 2023, Volume and Issue: 66(8), P. 2095 - 2105

Published: Aug. 17, 2023

Language: Английский

Citations

9

The BRD4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells DOI Creative Commons
Shunhong Luo, Jiaming Tian, Yi Chu

et al.

Cell Death and Disease, Journal Year: 2023, Volume and Issue: 14(11)

Published: Nov. 23, 2023

Abstract Lipid metabolism is the key to ferroptosis susceptibility. However, little known about underlying mechanisms in osteosarcoma cells. Functional restriction of bromodomain-containing protein 4 (BRD4) reduced susceptibility erastin-induced cells both vitro and vivo. Mechanically, BRD4 controls splicing efficiency RNA precursor (pre-mACSL3) ACSL3 (ACSL3) by recruiting serinerich/threonine kinase 2 (SRPK2) assemble catalytic platform. Moreover, AMP-binding domain significantly influences arachidonic acid synthesis thus determines ferroptosis. Overall, we found a BRD4-mediated pre-mACSL3 affecting Data this study fills some gap understanding post-transcriptional regulatory provides new insights into lipid regulation its effect on

Language: Английский

Citations

9